Company research
Q BioMed Inc.
CIK 1596062Updated Sep 24, 2026
Securities
Historical securities (1)
QBIO · OTC · equity · closed Mar 30, 2026Name history
ISMO Tech Solutions, Inc. · through Jul 15, 2015
QBIO price & chart
Historical security
This listing closed Mar 30, 2026. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 3,515,517Source | 809,480Source | 623,484Source | 640,298Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 177,145Source | 172,636Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 11,535Source | 80,097Source | — | — |
| Assets, CurrentUSD | 72,316Source | 459,480Source | 223,484Source | 190,298Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,808Source | 35,374Source | 46,339Source | 17,662Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 8,132,940Source | 5,494,842Source | 1,698,965Source | 5,685,639Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 84,328Source | 28,648Source | 23,816Source | 19,709Source |
| Additional Paid in CapitalUSD | 56,308,513Source | 53,335,901Source | 47,656,423Source | 37,328,827Source |
| Retained Earnings (Accumulated Deficit)USD | -66,095,802Source | -64,126,618Source | -55,886,068Source | -42,393,877Source |
| Stockholders' Equity Attributable to ParentUSD | -4,617,422Source | -4,685,362Source | -1,075,481Source | -5,045,341Source |
| Liabilities and EquityUSD | 3,515,517Source | 809,480Source | 623,484Source | 640,298Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 8,132,940Source | 5,494,842Source | 1,698,965Source | 5,238,304Source |
| Accounts Payable, CurrentUSD | 2,132,063Source | 1,345,319Source | 721,744Source | 652,051Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,545,052Source | 954,309Source | 837,660Source | 1,145,660Source |
| Long-term DebtUSD | — | — | — | 447,335Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -10,279,730Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 392,002Source | 2,338,580Source | 5,834,639Source | 2,496,296Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -68,563Source | 80,097Source | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | 324,009Source | — |
| Increase (Decrease) in Accounts PayableUSD | 1,474,728Source | 838,693Source | 569,193Source | 1,405,481Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 1,941,404Source | -4,302,036Source | -6,233,441Source | -4,105,027Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -3,143,201Source | — | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 907,761Source | 4,468,900Source | 6,237,950Source | 1,593,250Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 49,973Source | 344,009Source | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | 441Source | — | 31,524Source |
| Income Taxes Paid, NetUSD | 0Source | 0Source | — | — |
| Additional Financial Items | ||||
| AmortizationUSD | 50,000Source | 50,000Source | 50,000Source | 50,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | -384,311Source | -40,910Source | -31,399Source | — |
| General and Administrative ExpenseUSD | 3,311,249Source | 6,263,475Source | 10,969,253Source | 4,480,577Source |
| Inventory Write-downUSD | — | — | 324,009Source | — |
| Net Income (Loss) Attributable to ParentUSD | -2,052,093Source | -8,240,550Source | -13,492,191Source | -10,279,730Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -3,494,084Source | -8,741,274Source | -14,350,215Source | — |
| Operating ExpensesUSD | 3,436,628Source | 7,337,316Source | 12,849,405Source | 8,019,958Source |
| Other Nonoperating Income (Expense)USD | 1,393,523Source | — | — | — |
| Payments to Acquire InvestmentsUSD | 3,143,201Source | — | — | — |
| Unrealized Gain (Loss) on DerivativesUSD | 273,783Source | — | — | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 284,352Source | 195,597Source | 30,000Source | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -3,445,616Source | — | — | — |
| Other Nonoperating Income (Expense)USD | 1,393,523Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -7,388,565Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -2,052,093Source | -8,240,550Source | -13,492,191Source | -10,279,730Source |
| Earnings Per Share, BasicUSD per share | -0.08Source | -0.33Source | — | — |
| Earnings Per Share, DilutedUSD per share | -0.08Source | -0.33Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 44,756,818Source | 26,779,270Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 44,756,818Source | 26,779,270Source | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 3,311,249Source | 6,263,475Source | 10,969,253Source | 4,480,577Source |
| Gross ProfitUSD | -8,988Source | -51,249Source | -296,009Source | — |
| Interest ExpenseUSD | 1,384,465Source | 506,922Source | 296,215Source | 1,460,384Source |
| Interest Expense, DebtUSD | 252,000Source | 96,000Source | 158,000Source | 327,966Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -3,494,084Source | -8,741,274Source | -14,350,215Source | — |
| Operating ExpensesUSD | 3,436,628Source | 7,337,316Source | 12,849,405Source | 8,019,958Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | 473,831Source | 500,724Source | 375,079Source | — |
| Research and Development ExpenseUSD | 125,378Source | 1,073,841Source | 1,880,152Source | 3,539,381Source |